← Back to Search

Stratified Transplant Survival Metric for Cardiac Dysfunction

N/A
Waitlist Available
Led By Alison E Butler, MS
Research Sponsored by Carnegie Mellon University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial is testing whether people judge organ transplant centers differently when they know how many organs each center accepts.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hospital Choice
Secondary outcome measures
Mediator of Hospital Choice

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Condition 4: Stratified Transplant SRTRExperimental Treatment2 Interventions
Participants randomized to Condition 4 will view only stratified transplant survival outcome information when making a choice between the two hospitals. The "survival following transplant" metric is displayed as a pair of quintile scores corresponding to two distinct groups of transplant patients at the center: those who received optimal donor organs and those who received adequate donor organs.
Group II: Condition 3: Combined Transplant SRTRExperimental Treatment1 Intervention
Participants randomized to Condition 3 will view only combined transplant survival outcome information (e.g. transplant survival rate not stratified by number and quality of donor hearts accepted at each center) when making a choice between the two hospitals. The "survival following transplant" metric is displayed as a quintile score corresponding to all patients at the center who received transplants.
Group III: Condition 2: Stratified Transplant PictographExperimental Treatment1 Intervention
Participants randomized to Condition 2 will view only stratified transplant survival outcome information when making a choice between the two hospitals. The "survival following transplant" metric is displayed as a pair of survival rate pictographs corresponding to two distinct groups of transplant patients at the center: those who received optimal donor organs and those who received adequate donor organs.
Group IV: Condition 1: Combined Transplant PictographActive Control1 Intervention
Participants randomized to baseline (control) arm Condition 1 will view only combined transplant survival outcome information (e.g. transplant survival rate not stratified by number and quality of donor hearts accepted at each center) when making a choice between the two hospitals. The "survival following transplant" metric is displayed as a survival rate pictograph corresponding to all patients at the center who received transplants.

Find a Location

Who is running the clinical trial?

Carnegie Mellon UniversityLead Sponsor
76 Previous Clinical Trials
539,836 Total Patients Enrolled
Alison E Butler, MSPrincipal InvestigatorCarnegie Mellon University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people have signed up to partake in this clinical investigation?

"Correct. According to the information available on clinicaltrials.gov, this scientific research is currently accepting candidates. It was initially posted in April 2021 and has been amended as recently as October 2022. 400 individuals need to be recruited from a single facility for the study's success."

Answered by AI

Can individuals currently join this clinical experiment?

"According to information provided on clinicaltrials.gov, this medical trial is actively searching for volunteers; the posting was first made available in April 2021 and last edited in October 2022."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Don't Throw Your Heart Away: Patient Study 4
Gretchen Chapman 2021. "Don't Throw Your Heart Away: Patient Study 4". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04809051.
~23 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top